http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1851452

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase III|Journal Article|Multicenter Study|Randomized Controlled Trial
endingPage 90
issn 1433-0563
issueIdentifier 9
pageRange 1287-90
publicationName Der Urologe. Ausg. A
startingPage 1287
bibliographicCitation Rexer H. [Study on therapy of metastasized or locally advanced urothelial cancer: A phase III randomized clinical trial of pembrolizumab (MK-3475) versus paclitaxel, docetaxel or vinflunine in subjects with recurrent or progressive metastatic urothelial cancer (Keynote 045) - AP 48/15 der AUO]. Urologe A. 2015 Sep;54(9):1287–90. doi: 10.1007/s00120-015-3934-9. PMID: 26337168.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97c3283016b55495e65d1ee45e09bb70
date 201509
identifier https://pubmed.ncbi.nlm.nih.gov/26337168
https://doi.org/10.1007/s00120-015-3934-9
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/7905
https://portal.issn.org/resource/ISSN/1433-0563
language German
source https://pubmed.ncbi.nlm.nih.gov/
https://scigraph.springernature.com/
https://www.crossref.org/
title [Study on therapy of metastasized or locally advanced urothelial cancer: A phase III randomized clinical trial of pembrolizumab (MK-3475) versus paclitaxel, docetaxel or vinflunine in subjects with recurrent or progressive metastatic urothelial cancer (Keynote 045) - AP 48/15 der AUO]
discusses http://id.nlm.nih.gov/mesh/M0443608
http://id.nlm.nih.gov/mesh/M0288082
http://id.nlm.nih.gov/mesh/M0586473
http://id.nlm.nih.gov/mesh/M0022672
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0026156
http://id.nlm.nih.gov/mesh/M0184558
http://id.nlm.nih.gov/mesh/M0556300
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D061067Q000008
http://id.nlm.nih.gov/mesh/D017239Q000008
http://id.nlm.nih.gov/mesh/D043823Q000008
http://id.nlm.nih.gov/mesh/D009364Q000188
http://id.nlm.nih.gov/mesh/D014747Q000031
hasSubjectTerm http://id.nlm.nih.gov/mesh/D061067Q000009
http://id.nlm.nih.gov/mesh/D017239Q000009
http://id.nlm.nih.gov/mesh/D009361
http://id.nlm.nih.gov/mesh/D014747Q000008
http://id.nlm.nih.gov/mesh/D000077143
http://id.nlm.nih.gov/mesh/D005858
http://id.nlm.nih.gov/mesh/D014747Q000009
http://id.nlm.nih.gov/mesh/D043823Q000009
http://id.nlm.nih.gov/mesh/D005060
http://id.nlm.nih.gov/mesh/D009364Q000473
http://id.nlm.nih.gov/mesh/D000970Q000009
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D014481
http://id.nlm.nih.gov/mesh/D000970Q000008
http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918295
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21874242
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118218024
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10629256
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603

Showing number of triples: 1 to 56 of 56.